Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
May 3, 2007

Amylin Selects Ohio as Site for Expansion of Production Plant

  • Amylin is increasing construction at the manufacturing facility in West Chester, OH, to increase investment to a total of approximately $400 million.

    The company is expanding its existing production plant near the Union Center Boulevard district, which is now in the process of being equipped to manufacture it long-acting release (LAR) formulation of exenatide, a compound in development for type 2 diabetes.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »